Capricor Therapeutics Inc (FRA:4LN2)
€ 3.7 +0.37 (+10.98%) Market Cap: 206.04 Mil Enterprise Value: -22.90 Mil PE Ratio: 0 PB Ratio: 0.95 GF Score: 54/100

Capricor Therapeutics Inc (FRA:4LN2) Transcripts

  • 1